People in chronic pain show higher suicide risk

NEW YORK (Reuters Health) - People with severe headaches or other forms of chronic pain may have an increased risk of suicide, a study published Tuesday suggests.

The study, of nearly 5,700 U.S. adults, found that those who reported chronic pain other than arthritis were four times more likely to have attempted suicide than adults not suffering from persistent pain.

Head pain and pain in multiple areas of the body were particularly linked to suicidal thoughts and behavior, according to researchers at the University of Michigan Ann Arbor.

They found that men and women with frequent or severe headaches were twice as likely to have either contemplated or attempted suicide. These risks were also elevated among study participants who reported multiple forms of pain.

Among those with three or more painful conditions, 14 percent said they had ever thought about suicide, while nearly 6 percent reported an actual suicide attempt.

“Pain is one of those factors that may make someone feel more hopeless and less optimistic about the future and increases the chances that they will think about suicide,” lead researcher Dr. Mark A. Ilgen said in a written statement.

The vast majority of people with painful health conditions will not become suicidal, noted Ilgen, a psychologist at the Ann Arbor VA Hospital.

However, the findings do bolster evidence of a higher-than-average suicide risk among people in chronic pain, Ilgen and his colleagues report in the journal General Hospital Psychiatry.

Studies have, for example, found that migraine sufferers have heightened risks of depression and suicidal behavior.

In the current study, just under 8 percent of people who reported frequent or severe headaches said they had thought about committing suicide, compared with 2 percent of adults with no chronic head pain.

Even when the researchers accounted for other factors — such as whether participants suffered from any psychiatric disorder — pain itself remained linked to suicidal behavior.

“This is further evidence that we need to be aware of the heightened risk for suicide in those with chronic pain,” Ilgen said. “More work is needed to figure out who’s going to be at the greatest risk and how can we intervene and decrease this risk.”

SOURCE: General Hospital Psychiatry, November/December 2008.


Related Posts:

By Ransdell Pierson NEW YORK (Reuters) - U.S. regulators on Tuesday said their review of clinical trials does not suggest Merck & Co’s Singulair asthma drug or similar medicines cause suicide or suicidal thought, although the data were inadequate to draw a firm conclusion. However, the U.S. Food and Drug Administration said it was continuing to review

Full Post: FDA says Singulair data do not suggest suicide link

WASHINGTON (Reuters) - Acupuncture works better than drugs like aspirin to reduce the severity and frequency of chronic headaches, U.S. researchers reported on Monday. A review of studies involving nearly 4,000 patients with migraine, tension headache and other forms of chronic headache showed that that 62 percent of the acupuncture patients reported headache relief compared to

Full Post: Acupuncture beats aspirin for chronic headache

By Joene Hendry NEW YORK (Reuters Health) - Suicide has not declined among elderly people living in long-term care facilities as it has among community-living elders, research hints. In a review of the 1,771 suicide deaths between 1990 and 2005 among New York City residents aged 60 and older, researchers found a significant decrease in the relative

Full Post: Elder suicide risk persists in long-term care

NEW YORK (Reuters Health) - Being overweight or obese may increase the likelihood of having severe headaches and migraines, new study findings suggest. An increased prevalence of headache may be associated with being underweight as well. In analyses of 7,601 adult men and women, Dr. Earl S. Ford and colleagues at the U.S. Centers for Disease

Full Post: Obesity may raise headache risk

WASHINGTON (Reuters) - Makers of epilepsy drugs must add a warning that the medicines carry a risk of suicidal thoughts or actions, U.S. health officials said on Tuesday. “The risk of suicidal thoughts or behavior was generally consistent among the eleven drugs analyzed and was observed in patients who were treated for epilepsy, psychiatric disorders, and

Full Post: FDA orders suicidal action warning on epilepsy drugs

Site Navigation

Most Read